276 related articles for article (PubMed ID: 20043465)
21. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
22. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
[TBL] [Abstract][Full Text] [Related]
23. Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.
Droc C; Cualing HD; Kadin ME
Cancer Control; 2007 Apr; 14(2):124-32. PubMed ID: 17387297
[TBL] [Abstract][Full Text] [Related]
24. Anaplastic large cell lymphoma of scrotal skin.
Mehdi I; Praseeda I; Al-Bahrani BJ; Satayapal N; Monem AA; Al Kharusi S
J Pak Med Assoc; 2011 Nov; 61(11):1140-3. PubMed ID: 22126000
[TBL] [Abstract][Full Text] [Related]
25. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.
Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W
J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
Lee WJ; Moon IJ; Lee SH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
[TBL] [Abstract][Full Text] [Related]
27. Practical Management of CD30⁺ Lymphoproliferative Disorders.
Hughey LC
Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
[TBL] [Abstract][Full Text] [Related]
28. Brentuximab vedotin in CD30
Enos TH; Feigenbaum LS; Wickless HW
Int J Dermatol; 2017 Dec; 56(12):1400-1405. PubMed ID: 28762479
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate.
Fujita H; Nagatani T; Miyazawa M; Wada H; Koiwa K; Komatsu H; Ikezawa Z
Eur J Dermatol; 2008; 18(3):360-1. PubMed ID: 18474486
[No Abstract] [Full Text] [Related]
30. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
[TBL] [Abstract][Full Text] [Related]
31. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE
Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
[TBL] [Abstract][Full Text] [Related]
32. FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.
Gjerdrum LM; Woetmann A; Odum N; Hother C; Henrik-Nielsen R; Gniadecki R; Ralfkiaer E
Eur J Haematol; 2008 Jun; 80(6):483-9. PubMed ID: 18331599
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
[TBL] [Abstract][Full Text] [Related]
34. Low-dose radiotherapy for primary cutaneous anaplastic large-cell lymphoma while on low-dose methotrexate.
Cornejo CM; Novoa RA; Krisch RE; Kim EJ
Cutis; 2016 Oct; 98(4):253-256. PubMed ID: 27874877
[TBL] [Abstract][Full Text] [Related]
35. Lymphohistiocytic anaplastic large cell lymphoma involving skin: a diagnostic challenge.
Chuang SS; Hsieh YC; Ye H; Hwang WS
Pathol Res Pract; 2009; 205(4):283-7. PubMed ID: 19091487
[TBL] [Abstract][Full Text] [Related]
36. The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: a study of 53 cases.
Kiran T; Demirkesen C; Eker C; Kumusoglu H; Tuzuner N
Leuk Res; 2013 Apr; 37(4):396-400. PubMed ID: 23332472
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous CD30 positive anaplastic large cell lymphoma in an adolescent.
Vaid R; Cohen B
Pediatr Dermatol; 2009; 26(6):721-4. PubMed ID: 20199449
[TBL] [Abstract][Full Text] [Related]
38. Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders.
Kamstrup MR; Ralfkiaer E; Skovgaard GL; Gniadecki R
Br J Dermatol; 2008 Apr; 158(4):747-53. PubMed ID: 18241263
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
[TBL] [Abstract][Full Text] [Related]
40. Perils and pitfalls regarding differential diagnosis and treatment of primary cutaneous anaplastic large-cell lymphoma.
Diamantidis MD; Myrou AD
ScientificWorldJournal; 2011 May; 11():1048-55. PubMed ID: 21552770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
